STAGE IIIA NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in early cancer trial
Disease control OngoingThis early-phase trial tests a new drug called sEphB4-HSA combined with standard chemotherapy in people with advanced or metastatic solid tumors, including head and neck, pancreatic, lung, and gallbladder cancers. The goal is to find the best dose and see if the combination is sa…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope: targeted pill before surgery for lung cancer
Disease control OngoingThis study tests whether giving the targeted drug osimertinib before surgery can shrink tumors in people with early-stage EGFR-mutant non-small cell lung cancer. About 27 adults with stage I to IIIA disease will receive the drug before their operation. The main goal is to see how…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to boost lung cancer fight
Disease control OngoingThis trial is testing a new way to give radiation therapy for people with stage II-III non-small cell lung cancer that cannot be removed with surgery. Instead of standard daily radiation for many weeks, patients receive a shorter, higher-dose course (hypofractionated radiation) a…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC